LIFE SCIENCES

Our life sciences group serves public and private companies in the biotechnology, specialty pharma, and other sectors. Services our firm offers include:

• Integrated audits of financial statements and internal control over financial reporting for public companies
• Financial statement audits for private companies, including assistance with going public
• Assisting with capital market financing transactions – as independent auditors we have participated in twenty public and private offerings totaling more than $300 million since 2005
• Accounting guidance on complex or unusual transactions, such as revenue recognition for collaborative arrangements, debt and equity financings, and business combinations
• Financial due diligence on mergers and acquisitions
• Federal and state corporate income tax compliance
• Federal and state change of ownership (IRC Section 382) and research and development credit studies
• Income tax provisions for public companies under SFAS No. 109 and FIN No. 48
• Consulting on tax matters, including deferred compensation issues under IRC Section 409A, intercompany transfer pricing, tax planning strategies, and international taxation